Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Oct 1:4:293.
doi: 10.3389/fmicb.2013.00293.

Virus-induced exacerbations in asthma and COPD

Affiliations
Review

Virus-induced exacerbations in asthma and COPD

Daisuke Kurai et al. Front Microbiol. .

Abstract

Chronic obstructive pulmonary disease (COPD) is characterized by chronic airway inflammation and/or airflow limitation due to pulmonary emphysema. Chronic bronchitis, pulmonary emphysema, and bronchial asthma may all be associated with airflow limitation; therefore, exacerbation of asthma may be associated with the pathophysiology of COPD. Furthermore, recent studies have suggested that the exacerbation of asthma, namely virus-induced asthma, may be associated with a wide variety of respiratory viruses. COPD and asthma have different underlying pathophysiological processes and thus require individual therapies. Exacerbation of both COPD and asthma, which are basically defined and diagnosed by clinical symptoms, is associated with a rapid decline in lung function and increased mortality. Similar pathogens, including human rhinovirus, respiratory syncytial virus, influenza virus, parainfluenza virus, and coronavirus, are also frequently detected during exacerbation of asthma and/or COPD. Immune response to respiratory viral infections, which may be related to the severity of exacerbation in each disease, varies in patients with both COPD and asthma. In this regard, it is crucial to recognize and understand both the similarities and differences of clinical features in patients with COPD and/or asthma associated with respiratory viral infections, especially in the exacerbative stage. In relation to definition, epidemiology, and pathophysiology, this review aims to summarize current knowledge concerning exacerbation of both COPD and asthma by focusing on the clinical significance of associated respiratory virus infections.

Keywords: COPD; asthma; exacerbation; human rhinovirus; overlap syndrome; respiratory syncytial virus; respiratory virus.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Human respiratory pathogens associated with asthma exacerbations. Pathogens are divided into three categories as bacteria, RNA viruses, or DNA viruses. Red and yellow columns are the most relevant pathogens in order.
FIGURE 2
FIGURE 2
Human respiratory pathogens associated with exacerbations of COPD. Red and yellow columns are the most relevant pathogens in order.
FIGURE 3
FIGURE 3
Multidisciplinary assessment for asthma exacerbation. PCR, polymerase-chain reaction; RT-PCR, real-time PCR; BALF, bronchoalveolar lavage fluid; GERD, gastroesophageal reflux disease; ASA, acetylsalicylic acid; NSAIDS, non-steroidal anti-inflammatory drugs; SABA, short-acting β-agonist inhalers; GINA, Global Initiative for Asthma; ABPA, allergic bronchopulmonary aspergillosis; EPR, expert panel report.
FIGURE 4
FIGURE 4
Viral detection in exacerbations of COPD using PCR or RT-PCR methods in recent studies. Picornaviruses include human rhinovirus and human enterovirus. Multiple viruses were detected in individual patients per one episode.

References

    1. Aaron S. D., Angel J. B., Lunau M., Wright K., Fex C., Le Saux N., et al. (2001). Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 163 349–355 10.1164/ajrccm.163.2.2003122 - DOI - PubMed
    1. Abramson M., Pearson L., Kutin J., Czarny D., Dziukas L., Bowes G. (1994). Allergies, upper respiratory tract infections, and asthma. J. Asthma 31 367–374 10.3109/02770909409061316 - DOI - PubMed
    1. Albert R. K., Connett J., Bailey W. C., Casaburi R., Cooper J. A., Jr., Criner G. J., et al. (2011). Azithromycin for prevention of exacerbations of COPD. N. Engl. J. Med. 365 689–698 10.1056/NEJMoa1104623 - DOI - PMC - PubMed
    1. Atmar R. L., Guy E., Guntupalli K. K., Zimmerman J. L., Bandi V. D., Baxter B. D., et al. (1998). Respiratory tract viral infections in inner-city asthmatic adults. Arch. Intern. Med. 158 2453–2459 10.1001/archinte.158.22.2453 - DOI - PubMed
    1. Bafadhel M., Mckenna S., Terry S., Mistry V., Reid C., Haldar P., et al. (2011). Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am. J. Respir. Crit. Care Med. 184 662–671 10.1164/rccm.201104-0597OC - DOI - PubMed